The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in.the regions governing ligand specificity

被引:103
作者
Lou, Meizhen
Garrett, Thomas P. J.
McKern, Neil M.
Hoyne, Peter A.
Epa, V. Chandana
Bentley, John D.
Lovrecz, George O.
Cosgrove, Leah J.
Frenkel, Maurice J.
Ward, Colin W.
机构
[1] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
[2] Commonwealth Sci & Ind Res Org, Div Mol & Hlth Technol, Parkville, Vic 3052, Australia
关键词
crystal structure; ectodomain; insulin-binding site;
D O I
10.1073/pnas.0605395103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The insulin receptor (IR) and the type-1 insulin-like growth factor receptor (IGF1R) are homologous multiclomain proteins that bind insulin and IGFwith differing specificity. Here we report the crystal structure of the first three domains (L1-CR-L2) of human IR at 2.3 A resolution and compare it with the previously determined structure of the corresponding fragment of IGF1R. The most important differences seen between the two receptors are in the two regions governing ligand specificity. The first is atthe corner of the ligand-binding surface of the L1 domain, where the side chain of F39 in IR forms part of the ligand binding surface involving the second (central) beta-sheet. This is very different to the location of its counterpart in IGF1R, S35, which is not involved in ligand binding. The second major difference is in the sixth module of the CR domain, where IR contains a larger loop that protrudes further into the ligand-binding pocket. This module, which governs IGF1-binding specificity, shows negligible sequence identity, significantly more a-helix, an additional disulfide bond, and opposite electrostatic potential compared to that of the IGHR.
引用
收藏
页码:12429 / 12434
页数:6
相关论文
共 56 条
[1]   Structure and function of the type 1 insulin-like growth factor receptor [J].
Adams, TE ;
Epa, VC ;
Garrett, TPJ ;
Ward, CW .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (07) :1050-1093
[2]  
ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681
[3]  
BAYNE ML, 1988, J BIOL CHEM, V263, P6233
[4]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[5]  
BRUNGER AT, 1996, XPLOR REFERENCE MANU
[6]   Insulinand its receptor: structure, function and evolution [J].
De Meyts, P .
BIOESSAYS, 2004, 26 (12) :1351-1362
[7]   Structural biology of insulin and IGF1 receptors: Implications for drug design [J].
De Meyts, P ;
Whittaker, J .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (10) :769-783
[8]   IDENTIFICATION OF A LIGAND-BINDING REGION OF THE HUMAN INSULIN-RECEPTOR ENCODED BY THE 2ND EXON OF THE GENE [J].
DEMEYTS, P ;
GU, JL ;
SHYMKO, RM ;
KAPLAN, BE ;
BELL, GI ;
WHITTAKER, J .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (03) :409-416
[9]   PHENOL STABILIZES MORE HELIX IN A NEW SYMMETRICAL ZINC INSULIN HEXAMER [J].
DEREWENDA, U ;
DEREWENDA, Z ;
DODSON, EJ ;
DODSON, GG ;
REYNOLDS, CD ;
SMITH, GD ;
SPARKS, C ;
SWENSON, D .
NATURE, 1989, 338 (6216) :594-596
[10]   X-RAY-ANALYSIS OF THE SINGLE CHAIN-B29-A1 PEPTIDE-LINKED INSULIN MOLECULE - A COMPLETELY INACTIVE ANALOG [J].
DEREWENDA, U ;
DEREWENDA, Z ;
DODSON, EJ ;
DODSON, GG ;
BING, X ;
MARKUSSEN, J .
JOURNAL OF MOLECULAR BIOLOGY, 1991, 220 (02) :425-433